These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7734422)

  • 1. Mutations in residue 61 of H-Ras p21 protein influence MHC class II presentation.
    Ngo-Giang-Huong N; Kayibanda M; Deprez B; Levy JP; Guillet JG; Tilkin AF
    Int Immunol; 1995 Feb; 7(2):269-75. PubMed ID: 7734422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes.
    Peace DJ; Chen W; Nelson H; Cheever MA
    J Immunol; 1991 Mar; 146(6):2059-65. PubMed ID: 2005390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).
    Gedde-Dahl T; Spurkland A; Eriksen JA; Thorsby E; Gaudernack G
    Int Immunol; 1992 Nov; 4(11):1331-7. PubMed ID: 1282032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl.
    Cheever MA; Chen W; Disis ML; Takahashi M; Peace DJ
    Ann N Y Acad Sci; 1993 Aug; 690():101-12. PubMed ID: 8103658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
    Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
    Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides.
    Gedde-Dahl T; Eriksen JA; Thorsby E; Gaudernack G
    Hum Immunol; 1992 Apr; 33(4):266-74. PubMed ID: 1639630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells.
    Fossum B; Gedde-Dahl T; Hansen T; Eriksen JA; Thorsby E; Gaudernack G
    Eur J Immunol; 1993 Oct; 23(10):2687-91. PubMed ID: 7691613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).
    Fossum B; Gedde-Dahl T; Breivik J; Eriksen JA; Spurkland A; Thorsby E; Gaudernack G
    Int J Cancer; 1994 Jan; 56(1):40-5. PubMed ID: 7903287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21.
    Abrams SI; Dobrzanski MJ; Wells DT; Stanziale SF; Zaremba S; Masuelli L; Kantor JA; Schlom J; Masuelle L [corrected to Masuelli L]
    Eur J Immunol; 1995 Sep; 25(9):2588-97. PubMed ID: 7589131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.
    Gjertsen MK; Saeterdal I; Saebøe-Larssen S; Gaudernack G
    J Mol Med (Berl); 2003 Jan; 81(1):43-50. PubMed ID: 12545248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli.
    Fenton RG; Keller CJ; Hanna N; Taub DD
    J Natl Cancer Inst; 1995 Dec; 87(24):1853-61. PubMed ID: 7494229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unconventional cytotoxic T lymphocyte recognition of synthetic peptides corresponding to residues 1-23 of Ras protein.
    Yin L; Thomas C; Hsuan JJ; Stauss HJ
    Eur J Immunol; 1994 Sep; 24(9):1988-92. PubMed ID: 8088318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant ras epitopes as targets for cancer vaccines.
    Abrams SI; Hand PH; Tsang KY; Schlom J
    Semin Oncol; 1996 Feb; 23(1):118-34. PubMed ID: 8607022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes.
    Fenton RG; Taub DD; Kwak LW; Smith MR; Longo DL
    J Natl Cancer Inst; 1993 Aug; 85(16):1294-302. PubMed ID: 8340941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell recognition of a point mutation in the P21 Ras protein.
    Yin L; Lowe P; Stauss HJ
    Leukemia; 1993 Aug; 7 Suppl 2():S27-30. PubMed ID: 7689674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing.
    Brett SJ; Cease KB; Berzofsky JA
    J Exp Med; 1988 Jul; 168(1):357-73. PubMed ID: 2456373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.